Literature DB >> 21508107

Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy.

Shigeo Yoshida1, Keijiro Ishikawa, Ryo Asato, Mitsuru Arima, Yukio Sassa, Ayako Yoshida, Hiroshi Yoshikawa, Keisuke Narukawa, Satoshi Obika, Junya Ono, Shoichiro Ohta, Kenji Izuhara, Toshihiro Kono, Tatsuro Ishibashi.   

Abstract

PURPOSE: Preretinal fibrovascular membranes (FVMs) form as a sequela to proliferative diabetic retinopathy (PDR), and their presence can lead to a severe decrease of vision. The purpose of this study was to determine whether periostin, a matricellular protein that plays a role in cell adhesion and migration, is associated with the formation of FVMs.
METHODS: One hundred six vitreous samples and 15 FVMs were obtained during vitrectomy on patients with PDR. Semiquantitative RT-PCR was performed to determine the periostin level of the mRNA. Immunohistochemical analyses were performed to determine the sites of periostin expression in the FVMs. ELISA was used to measure the concentrations of periostin, bFGF, and VEGF in the vitreous.
RESULTS: The periostin level of the mRNA was high in 10 of 10 FVMs tested but was barely detectable in the control retinas. Sequencing of the periostin PCR products revealed three splice variants of the FVMs. Immunohistochemical analysis showed colocalization of periostin and α-SMA in FVM cells. The concentration of periostin in the vitreous was significantly higher in patients with PDR than in the 31 eyes of patients with a macular hole or an epiretinal membrane (P < 0.001). Among the PDR patients, the mean vitreous level of periostin in eyes with FVMs was significantly higher than in those without FVMs (epicenter only; P < 0.001). The correlation between the vitreous concentrations of periostin and of bFGF and VEGF was not significant.
CONCLUSIONS: These findings indicate that periostin may be involved in the development of FVMs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508107     DOI: 10.1167/iovs.10-6625

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

1.  Functional significance of periostin in excisional skin repair: is the devil in the detail?

Authors:  Christopher G Elliott; Shawna S Kim; Douglas W Hamilton
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

Review 2.  Roles of Periostin in Respiratory Disorders.

Authors:  Kenji Izuhara; Simon J Conway; Bethany B Moore; Hisako Matsumoto; Cecile T J Holweg; John G Matthews; Joseph R Arron
Journal:  Am J Respir Crit Care Med       Date:  2016-05-01       Impact factor: 21.405

Review 3.  Periostin in vitreoretinal diseases.

Authors:  Shigeo Yoshida; Takahito Nakama; Keijiro Ishikawa; Shintaro Nakao; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Cell Mol Life Sci       Date:  2017-09-14       Impact factor: 9.261

4.  Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop.

Authors:  Kazuto Taniguchi; Kazuhiko Arima; Miho Masuoka; Shoichiro Ohta; Hiroshi Shiraishi; Kanako Ontsuka; Shoichi Suzuki; Masako Inamitsu; Ken-Ichi Yamamoto; Olga Simmons; Shuji Toda; Simon J Conway; Yuhei Hamasaki; Kenji Izuhara
Journal:  J Invest Dermatol       Date:  2013-11-25       Impact factor: 8.551

5.  Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.

Authors:  T Nakama; S Yoshida; K Ishikawa; Y Kobayashi; Y Zhou; S Nakao; Y Sassa; Y Oshima; K Takao; A Shimahara; K Yoshikawa; T Hamasaki; T Ohgi; H Hayashi; A Matsuda; A Kudo; M Nozaki; Y Ogura; M Kuroda; T Ishibashi
Journal:  Gene Ther       Date:  2014-12-11       Impact factor: 5.250

6.  Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis.

Authors:  Kazuhiko Arima; Shoichiro Ohta; Atsushi Takagi; Hiroshi Shiraishi; Miho Masuoka; Kanako Ontsuka; Hajime Suto; Shoichi Suzuki; Ken-Ichi Yamamoto; Masahiro Ogawa; Olga Simmons; Yukie Yamaguchi; Shuji Toda; Michiko Aihara; Simon J Conway; Shigaku Ikeda; Kenji Izuhara
Journal:  Allergol Int       Date:  2014-10-23       Impact factor: 5.836

7.  Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV.

Authors:  Yoshiyuki Kobayashi; Shigeo Yoshida; Yedi Zhou; Takahito Nakama; Keijiro Ishikawa; Yuki Kubo; Mitsuru Arima; Shintaro Nakao; Toshio Hisatomi; Yasuhiro Ikeda; Akira Matsuda; Koh-Hei Sonoda; Tatsuro Ishibashi
Journal:  Lab Invest       Date:  2016-09-26       Impact factor: 5.662

8.  Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus.

Authors:  Y Ding; Q Ge; H Qu; Z Feng; J Long; Q Wei; Q Zhou; R Wu; L Yao; H Deng
Journal:  J Endocrinol Invest       Date:  2018-01-18       Impact factor: 4.256

9.  Increased expression of periostin and tenascin-C in eyes with neovascular glaucoma secondary to PDR.

Authors:  Keijiro Ishikawa; Ri-Ichiro Kohno; Kenichiro Mori; Yusuke Murakami; Shintaro Nakao; Masato Akiyama; Shigeo Yoshida; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-20       Impact factor: 3.117

Review 10.  Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy.

Authors:  Daniel Gologorsky; Aristomenis Thanos; Demetrios Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.